IT INCLUDES THE UPPER AND LOWER RESPIRATORY TRACK DISORDERS IN CHILDREN WITH THEIR PREVENTIVE MANAGEMENT. AND IN THIS SLIDE ALSO ENLISTED THE NURSING DIAGNOSIS.
Neural tube defects are birth defects of the brain, spine, or spinal cord. They happen in the first month of pregnancy, often before a woman even knows that she is pregnant. The two most common neural tube defects are spina bifida and anencephaly.
IT INCLUDES THE UPPER AND LOWER RESPIRATORY TRACK DISORDERS IN CHILDREN WITH THEIR PREVENTIVE MANAGEMENT. AND IN THIS SLIDE ALSO ENLISTED THE NURSING DIAGNOSIS.
Neural tube defects are birth defects of the brain, spine, or spinal cord. They happen in the first month of pregnancy, often before a woman even knows that she is pregnant. The two most common neural tube defects are spina bifida and anencephaly.
This is the second presentation on Scrotal Swellings. I have included unique classical clinical vignette, mind map and a tabular column to clinch the correct diagnosis.
Anomalies in development of face {pre and post} /certified fixed orthodontic...Indian dental academy
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and offering a wide range of dental certified courses in different formats.
Indian dental academy provides dental crown & Bridge,rotary endodontics,fixed orthodontics,
Dental implants courses.for details pls visit www.indiandentalacademy.com ,or call
0091-9248678078
#TeratologyLectureSlides
Teratology is the study of causes and mechanisms of abnormal developments.
These lectures slides will give you and concise overview teratology
which is a very important topic in course of Developmental Biology/Animal Development Biology
BSc Zoology
BS Zoology
BS Biotechnology
BSc Biotechnology
Lecture slides
development in animals ppt slides
concise lecture notes of teratology which give you an overview of teratology its causes and teratogens. Teratology is the science that studies the causes, mechanisms, and patterns of abnormal development.
Developmental disorders present at birth are called congenital anomalies, birth defect or congenital malformation.
Congenital anomalies are of four clinically significant types: malformation, disruption, deformation and dysplasia.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
2. A congenital anomaly is a structural abnormality of any
type that is present at birth.
Congenital anomalies may be induced by genetic or
environmental factors. Most common congenital
anomalies, however, show the family patterns expected of
multifactorial inheritance (determined by a combination
of genetic and environmental factors).
About 3% of all liveborn infants have an obvious major
anomaly.
The incidence is about 6% in 2-year-olds and 8% in 5-
year-olds.
Congenital anomalies may be single or multiple and of
minor or major clinical significance.
3. During the first 2 weeks of development, teratogenic agents
usually kill the embryo or have no effect.
During the organogenesis period (3rd – 8th weeks),
teratogenic agents disrupt development and may cause major
congenital anomalies.
During the fetal period (9th week – 9th month) teratogens may
produce morphological and functional abnormalities,
particularly of the brain and eyes.
4. Causes of congenital
anomalies;
1-Genetic factors such as chromosomal abnormalities
and mutant genes.
2-Environmental factors e.g.: the mother had German
measles in early pregnancy will cause abnormality in
the embryo.
3-Combined genetic and environmental factors
(mutlifactorials factors).
5. Types of abnormalities
Malformations: this occurs during the formation of the
structures of the organ (during organogenesis) results in
partial or complete non formation or alterations in the normal
structure. This occurs in the 3rd to the 8th week of gestation.
Ex. Cleft lip and or cleft palate.
Disruptions: results in morphological change of the already
formed structure due to exposure to destructive process. e.g.:
vascular accidents leading to intestinal atresia, amniotic band
disruption.
Deformations: due to mechanical forces that affect a part of
the fetus over a long period. Ex: talipes equinovarus
deformity.
Syndrome: is a group of anomalies occurring together due to
a common cause .
6. The genetic factors leading to congenital anomalies may be
due to chromosomal abnormalities, gene mutations or may be
multifactorial..
Chromosomal abnormalities occur due to:
- late maternal age at the time of pregnancy
(leads to chromosomal non-disjunction),
- radiation (causes chromosome deletions,translocations or
breaks),
- viruses as German measles,
- autoimmune diseases,
- and some chemical agents as anti-biotic drugs.
7. Syndrome examples
• CHARGE
– Colobomas
– Heart defects
– Atresia of the choanae
– Retarded growth
– Genital anomolies
– Ear anomalies
• VACTERL
– Verterbral anomalies (A)
– Anal A
– Cardiac A
– Tracheoesophageal A
– Renal A
– Limb A
9. Infectious Agents
• Rubella (German Measles)
– Malformations of the eye
• Cataract (6th week)
• Microphthalmia
– Malformations of the ear (9th week)
• Congenital deafness
– Due to destruction of cochlea
– Malformations of the heart (5th -10th week)
• Patent ductus arteriosis
• Atrial septal defects
• Ventricular septal defects
10. Infectious Agents (cont.)
• Rubella (German measles)
– May be responsible for some brain abnormalities
• Mental retardation
– Intrauterine growth retardation
– Myocardial damage
– Vascular abnormalites
– Incidence
• 47%- during 1st four weeks
• 22% - 5th – 8th weeks
• 13% - 9th – 16th week
11. Infectious Agents (cont.)
• Cytomegalovirus
– Disease is often fatal early on
– Malformations
• Microcephaly
– Cerebral calcifications
– Blindness
• Chorioretinitis
– Kernicterus (a form of jaundice)
– multiple petechiae of skin
– Hepatosplenomegaly
12. Infectious Agents (cont.)
• Herpes Simplex Virus
– Intrauterine infection of fetus occasionally occurs
– Usually infection is transmitted close to time of delivery
– Abnormalities (rare)
• Microcephaly
• Microphthalmos
• Retinal dysplasia
• Hepatosplenomegaly
• Mental retardation
– Usually child infected by mother at birth
• Inflammatory reactions during first few weeks
13. Infectious Agents (cont.)
• Varicella (chickenpox)
– Congenital anomalies
• 20% incidence following infection in 1st trimester
• Limb hypoplasia
• Mental retardation
• Muscle atrophy
• HIV/AIDS
– Microcephaly
– Growth retardation
– Abnormal facies (expression or appearance of the face)
14. Infectious Agents (cont.)
• Toxoplamosis
– Protozoa parasite (Toxoplama gondii)
• Sources
– Poorly cooked meat
– Domestic animals (cats)
– Contaminated soil with feces
• Syphilis
– Congenital deafness
– Mental retardation
– Diffuse fibrosis of organs (eg. liver & lungs)
• In general most infections are pyrogenic
– Hyperthemia can be teratogenic
• Fever
15. Radiation
• Teratogenic effect of ionizing radiation well established
– Microcephaly
– Skull defects
– Spina bifida
– Blindness
– cleft palate
– Extremity defects
• Direct effects on fetus or indirect effects on germ cells
• May effect succeeding generations
• Avoid X-raying pregnant women
16. Chemical agents/Drugs
• Role of chemical agents & drugs in production of anomalies is
difficult to assess
– Most studies are retrospective
• Relying on mother’s memory
– Large # of pharmaceutical drugs used by pregnant women
• NIH study – 900 drugs taken by pregnant women
– Average of 4/woman during pregnancy
– Only 20% of women use no drugs during pregnancy
– Very few drugs have been positively identified as being
teratogenic
17. Drugs
• Thalidomide
– Antinauseant & sleeping pill
– Found to cause amelia & meromelia
• Total or partial absence of the extremities
– Intestinal atresia
– Cardiac abnormalities
– Many women had taken thalidomide early in pregnancy (in
Germany in 1961)
19. Drugs (cont.)
• Anticonvulsants (to treat epilepsy)
– Diphenylhydantoin (phenytoin)
• Craniofacial defects
• Nail & digital hypoplasia
• Growth abnormalities
• Mental deficiency
• The above pattern is know as “fetal hydantoin
syndrome”
– Valproic acid
• Neural tube defects
• Heart defects
• Craniofacial & limb anomalies
20. Drugs (cont.)
• Antipsychotic drugs (major tranquilizers)
– Phenothiazine & lithium
• Suspected teratogenic agents
• Antianxiety drugs (minor tranquilizers)
– Meprobamate, chlordiazepoxide,
• Severe anomalies in 11-12% of offspring where
mothers were treated with the above compared to 2.6%
of controls
– diazepam (valium)
• Fourfold in cleft lip with or without cleft palate
21. Drugs (cont.)
• Anticoagulants
– Warfarin (A.K.A cumadin or cumarol)
• Teratogenic
• Hypoplasia of nasal cartilage
• Chondrodysplasia
• Central nervous system defects
– Mental retardation
– Atrophy of the optic nerves
• Antihypertensive agents
– angiotensin converting enzyme (ACE) inhibitor
• Growth dysfunction, renal dysfunction, oliogohydramnios,
fetal death
23. Alcohol
• Relationship between alcohol consumption & congenital
abnormalities
• Fetal alcohol syndrome
– Craniofacial abnormalities
• Short palpebral fissures
• Hypoplasia of the maxilla
– Limb deformities
• Altered joint mobility & position
– Cardiovascular defects
• Ventricular septal abnormalites
– Mental retardation
– Growth deficiency
24. Cigarette Smoking
• Has not been linked to major birth defects
– Smoking does contribute to intrauterine growth retardation
& premature delivery
– Some evidence that is causes behavioral disturbances
25. Hormones
• Androgenic Agents
– Synthetic progestins were used frequently to prevent
abortion
• Ethisterone & norethisterone
– Have considerable androgenic activity
» Masculinization of female genitalia
• Diethylstilbesterol
– Commonly used in the 1940’s & 1950’s to prevent
abortion; in 1971 determined that DES caused
increased incidence of vaginal & cervical cancer in
women who had been exposed to DES in utero
– In addition high % suffered from reproductive
dysfunction
• Oral Contraceptives
– Low teratogenic potential, discontinue if pregnancy
suspected
• Cortisone-cleft palate in mice (not humans)
26. Digestive system anom.)Cleft
lip/palate
• Incidence: about 1 in 600 live births
• Cleft lip with or without cleft palate
• Syndromic: associated with another syndrome. Syndromic
cleft lip/palate is more common in males
• Nonsyndromic: isolated finding, not associated with any
particular syndrome. Non syndromic tends to be equal
between males and females.
• Consider submucous cleft palate with bifid uvula
57. Prevention of birth defects
• Good prenatal care
• Iodine supplementation eliminates mental retardation & bone
deformities
– Prevent cretinism
• Folate/Folic Acid supplementation
– incidence of neural tube defects
• Avoidance of alcohol & other drugs during all stages of
pregnancy
– incidence of birth defects